BMY.RT

Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT

Overview Fund Activity
Delisted

BMY.RT was delisted on the 31st of December, 2020.

Back to rankings

3 hedge funds and large institutions have $4.66M invested in Bristol-Myers Squibb Company Contingent Value Rights in 2022 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, reducing their positions, and 0 closing their positions.

Holders
3
Holders Change
–
Holders Change %
0%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Market Value Shares Shares
Change 		Shares
Change %
JCI
1
Jet Capital Investors
New York
$4.66M 2,661,301 – –
MAM
2
Meeder Asset Management
Ohio
$0 5 – –
BCM
3
Beddow Capital Management
Wyoming
$0 572,879 – –